超声与磁共振及组织学方法定量肝脏脂肪的比较
这项前瞻性先导研究纳入56例经活检证实脂肪变性的个体,评估基于衰减(Att.PLUS)和声速(SSp.PLUS)的定量超声检测肝脏脂肪的能力,以组织病理学为参考标准,并与磁共振波谱(MRS)及MRI质子密度脂肪分数(MRI-PDFF)比较。结果显示两种定量超声参数在区分S0与S1+S2+S3时表现相当,但Att.PLUS可能更有效识别晚期脂肪变性(S2+S3),而MR技术优于定量超声方法。
要点
- Att.PLUS与SSp.PLUS在区分无脂肪变性与任何脂肪变性时AUC分别为0.79和0.78,表现相当。
- Att.PLUS在识别晚期脂肪变性(S2+S3)时AUC为0.93,可能优于SSp.PLUS的0.89。
- MR技术在肥胖及肝移植后患者中检测肝脂肪含量优于定量超声方法。
核心结论
- 两种定量超声参数在区分S0与S1+S2+S3患者时表现相当,但Att.PLUS参数可能更有效识别晚期脂肪变性(S2+S3);MR技术优于定量超声方法,更适合临床研究。
研究设计与样本
- 前瞻性先导研究,纳入56例经皮肝活检证实脂肪变性的个体(肝细胞内脂滴占0%至90%),以组织病理学为参考标准,使用Aixplorer MACH 30系统进行腹部定量超声检查(Att.PLUS和SSp.PLUS技术),并与MRS及MRI-PDFF(Siemens VIDA 3T系统)比较。
诊断标准与关键数值
- ROC分析(a):无脂肪变性(S0) vs 有脂肪变性(S1+S2+S3),Att.PLUS的AUC为0.79,SSp.PLUS的AUC为0.78,MRS和MRI-PDFF的AUC均>0.95。
- ROC分析(b):无或轻度脂肪变性(S0+S1) vs 严重脂肪变性(S2+S3),Att.PLUS的AUC为0.93,SSp.PLUS的AUC为0.89,MRS和MRI-PDFF的AUC均>0.99。
- 脂肪变性分级依据肝活检中肝细胞内脂滴所占比例(0%至90%),分为S0、S1、S2、S3。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This prospective pilot study aims to evaluate the capabilities of novel quantitative ultrasound (QUS) methods based on attenuation (Att.PLUS) and sound speed (SSp.PLUS) for detecting liver fat.
PATIENTS AND METHODS: The study included 56 individuals with biopsy-proven steatosis (percutaneous liver biopsy) ranging from 0 % to 90 % of hepatocytes containing intracellular lipid vacuoles. Histopathology was considered reference standard. Abdominal QUS examinations were conducted using Att.PLUS and SSp.PLUS techniques on the Aixplorer MACH 30 system. Comparative assessments were made using the results of liver biopsy and magnetic resonance spectroscopy (MRS) together with magnetic resonance imaging proton density fat fraction (MRI-PDFF). MR examinations were performed on the Siemens VIDA 3 T system.
RESULTS: ROC analysis was conducted for two groups: (a) patients without steatosis (S0) versus those with steatosis (S1 + S2 + S3) yielded AUC values of 0.79 for Att.PLUS and 0.78 for SSp.PLUS, in contrast to an AUC > 0.95 for MRS and MRI-PDFF; and (b) patients without or with mild steatosis (S0 + S1) versus those with severe steatosis (S2 + S3), yielded AUC values of 0.93 for Att.PLUS and 0.89 for SSp.PLUS, in contrast to an AUC > 0.99 for MRS and MRI-PDFF. However, MR methods were superior in detecting liver fat content in obese patients and post-liver transplantation individuals.
CONCLUSION: Both QUS parameters (Att.PLUS and SSp.PLUS) appear equivalent at differentiating S0 vs. (S1 + S2 + S3) patients, but the Att.PLUS parameter may be more effective at identifying advanced steatosis (S2 + S3). MR techniques outperformed QUS methods, making them more suitable for clinical studies.
引用
- Gottfriedova H, Dezortova M, Sedivy P, et al. Comparison of ultrasound to MR and histological methods for liver fat quantification. Eur J Radiol. 2025. PMID: 39837022. doi:10.1016/j.ejrad.2025.111931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。